Goldman Sachs’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.29B | Buy |
|
|||||
|
2025
Q1 | $4.4B | Buy |
|
|||||
|
2024
Q4 | $3.83B | Buy |
|
|||||
|
2024
Q3 | $4.12B | Sell |
|
|||||
|
2024
Q2 | $4.46B | Buy |
|
|||||
|
2024
Q1 | $3.52B | Sell |
|
|||||
|
2023
Q4 | $2.73B | Sell |
|
|||||
|
2023
Q3 | $2.6B | Sell |
|
|||||
|
2023
Q2 | $2.27B | Sell |
|
|||||
|
2023
Q1 | $1.95B | Buy |
|
|||||
|
2022
Q4 | $1.77B | Buy |
|
|||||
|
2022
Q3 | $1.54B | Buy |
|
|||||
|
2022
Q2 | $1.52B | Buy |
|
|||||
|
2022
Q1 | $1.29B | Buy |
|
|||||
|
2021
Q4 | $1.18B | Sell |
|
|||||
|
2021
Q3 | $1.1B | Buy |
|
|||||
|
2021
Q2 | $986M | Buy |
|
|||||
|
2021
Q1 | $801M | Buy |
|
|||||
|
2020
Q4 | $682M | Buy |
|
|||||
|
2020
Q3 | $529M | Sell |
|
|||||
|
2020
Q2 | $706M | Sell |
|
|||||
|
2020
Q1 | $668M | Sell |
|
|||||
|
2019
Q4 | $743M | Buy |
|
|||||
|
2019
Q3 | $576M | Sell |
|
|||||
|
2019
Q2 | $721M | Buy |
|
|||||
|
2019
Q1 | $723M | Sell |
|
|||||
|
2018
Q4 | $801M | Sell |
|
|||||
|
2018
Q3 | $800M | Buy |
|
|||||
|
2018
Q2 | $634M | Sell |
|
|||||
|
2018
Q1 | $704M | Buy |
|
|||||
|
2017
Q4 | $735M | Buy |
|
|||||
|
2017
Q3 | $657M | Sell |
|
|||||
|
2017
Q2 | $662M | Buy |
|
|||||
|
2017
Q1 | $624M | Sell |
|
|||||
|
2016
Q4 | $558M | Buy |
|
|||||
|
2016
Q3 | $487M | Sell |
|
|||||
|
2016
Q2 | $546M | Buy |
|
|||||
|
2016
Q1 | $213M | Sell |
|
|||||
|
2015
Q4 | $309M | Buy |
|
|||||
|
2015
Q3 | $244M | Sell |
|
|||||
|
2015
Q2 | $337M | Sell |
|
|||||
|
2015
Q1 | $362M | Sell |
|
|||||
|
2014
Q4 | $351M | Buy |
|
|||||
|
2014
Q3 | $320M | Sell |
|
|||||
|
2014
Q2 | $363M | Sell |
|
|||||
|
2014
Q1 | $425M | Buy |
|
|||||
|
2013
Q4 | $352M | Buy |
|
|||||
|
2013
Q3 | $312M | Buy |
|
|||||
|
2013
Q2 | $287M | Buy |
|